Search by Drug Name or NDC

    NDC 70934-0835-30 levocetirizine dihydrochloride 5 mg/1 Details

    levocetirizine dihydrochloride 5 mg/1

    levocetirizine dihydrochloride is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The primary component is LEVOCETIRIZINE DIHYDROCHLORIDE.

    Product Information

    NDC 70934-0835
    Product ID 70934-835_f1d83733-9b02-0d6b-e053-2a95a90abe84
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name levocetirizine dihydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name levocetirizine dihydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name LEVOCETIRIZINE DIHYDROCHLORIDE
    Labeler Name Denton Pharma, Inc. DBA Northwind Pharmaceuticals
    Pharmaceutical Class Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA203646
    Listing Certified Through n/a

    Package

    NDC 70934-0835-30 (70934083530)

    NDC Package Code 70934-835-30
    Billing NDC 70934083530
    Package 30 TABLET in 1 BOTTLE, PLASTIC (70934-835-30)
    Marketing Start Date 2021-03-05
    NDC Exclude Flag N
    Pricing Information N/A